FEops HEARTguide vs qXR-CTR
AI Verdict
Choose FEops HEARTguide if…
Choose FEops HEARTguide if you require advanced, patient-specific pre-procedural planning for complex structural heart interventions. This platform is ideal for optimizing device sizing and positioning through predictive simulations and digital twin technology, ensuring improved patient outcomes by meticulously evaluating device fit before surgery.
View FEops HEARTguide →Choose qXR-CTR if…
Choose qXR-CTR if your primary need is rapid, automated assessment of heart size from chest X-ray images for initial screening and risk stratification. This AI-powered solution efficiently measures the cardiothoracic ratio, providing a quick and objective metric to aid in identifying potential heart failure risk in a high-throughput setting.
View qXR-CTR →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | FEops HEARTguide | qXR-CTR |
|---|---|---|
| Deployment | Cloud Based platform | Can be deployed on cloud or on-premise. The Qure.ai app receives DICOM studies via DICOM network protocol from medical systems (PACS/Modality) or can import DICOM from the local system. The received DICOM study is processed in Qure's cloud server, and AI-processed reports are displayed on the app. |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
FEops HEARTguideFEops HEARTguide offers an interactive 2D and 3D viewer, along with semi-automatic identification and measurement of anatomical landmarks, providing a comprehensive and guided user experience for complex structural heart planning. While qXR-CTR automates a specific measurement, FEops HEARTguide provides more interactive control and detailed visualization for its intricate application.
Clinical Value
FEops HEARTguideFEops HEARTguide directly impacts structural heart procedure planning by providing predictive simulations to optimize device sizing and positioning, aiming for improved patient outcomes in complex interventions. qXR-CTR, while valuable for assessing heart size and heart failure risk, serves more as a screening and risk assessment tool, making Tool A's impact more direct and critical in individual patient treatment pathways for complex procedures.
Pricing & Value
TieBoth FEops HEARTguide and qXR-CTR require contacting the vendor for pricing, and neither provides publicly disclosed pricing details or models. Without this information, it is impossible to conduct a head-to-head comparison of their pricing and value propositions.
Enterprise Readiness
qXR-CTRqXR-CTR offers more flexible deployment options including cloud, on-premise, and hybrid, compared to FEops HEARTguide's cloud-based deployment. Additionally, qXR-CTR explicitly states it 'has_baa' (Business Associate Agreement), which is a key requirement for enterprise adoption, alongside both tools being HIPAA compliant and FDA cleared.
Innovation
FEops HEARTguideFEops HEARTguide leverages advanced 'digital twin technology' and 'predictive simulations' to create patient-specific replicas for structural heart procedure planning, representing a significant innovation in personalized medicine and surgical guidance. While qXR-CTR uses AI for automated measurement, the digital twin and predictive simulation approach of Tool A is more groundbreaking in its application.
Support & Docs
qXR-CTRQure.ai, the company behind qXR-CTR, provides extensive public documentation of its support and training infrastructure, including 24/7 support, dedicated teams, various communication channels (email, phone, chat, ticketing), and diverse training options like onboarding, webinars, and onsite sessions. While FEops HEARTguide offers a support email and mentions training materials, its publicly detailed support offerings are less comprehensive.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | FEops HEARTguide | qXR-CTR |
|---|---|---|
| Tool Name | FEops HEARTguide | qXR-CTR |
| Company | FEops NV | Qure.ai Technologies |
| Primary Use Case | Cloud-based AI and digital twin platform for structural heart procedure planning, providing predictive simulations and anatomical measurements. | AI-powered software that automates the measurement of the cardiothoracic ratio (CTR) from chest X-ray images. |
| Target Specialties | Cardiology, Cardiothoracic Surgery | Cardiology, Radiology |
| Core Technology | AI and digital twin platform with predictive simulation technology | AI-powered software for automated measurement |
| Input Data Type | CT scan (DICOM interface) | Chest X-ray images |
Videos
Demos, reviews, and walkthroughs featuring FEops HEARTguide and qXR-CTR.